Fig. 4From: Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implicationsCo-occurrence and mutual exclusivity of JAK3 germline activating mutation with mutations in ATM, MLH1, BRAF, and JAK2. Green and gray colors represent mutation and WT, respectivelyBack to article page